116 related articles for article (PubMed ID: 9617335)
1. [CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
Beppu M; Hiura M; Nogawa T; Kawakami Y; Yokoyama T; Chiba T
Gan To Kagaku Ryoho; 1998 May; 25(6):933-6. PubMed ID: 9617335
[TBL] [Abstract][Full Text] [Related]
2. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
Al-Saleh E; Hoskins PJ; Pike JA; Swenerton KD
Gynecol Oncol; 1997 Mar; 64(3):468-72. PubMed ID: 9062152
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent uterine cervical cancer successfully treated with etoposide].
Kobayashi H; Kawashima Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3279-82. PubMed ID: 2782919
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
6. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
Ikeda M; Noda K; Hiura M; Tamaya T; Ozaki M; Hatae M; Ozawa M; Yamabe T; Tanaka K; Izumi R; Okada H; Ogita Y; Hoshiai H
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
9. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
Panetta A; Angelelli B; Martoni A
Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
11. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
Tsuruchi N; Jimi S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):103-5. PubMed ID: 1729957
[TBL] [Abstract][Full Text] [Related]
13. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Matsui R; Kashihara K; Higashi T; Seo K; Taoka Y; Yoshida S; Nishitani H; Takegawa Y; Hukumura Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1985-8. PubMed ID: 8978808
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
16. [A patient with recurrent uterine cervical cancer successfully treated by combined modality therapy including local injection of anticancer agents based on CDDP].
Shiota M; Shirai T; Tateyama I
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2117-21. PubMed ID: 11103245
[TBL] [Abstract][Full Text] [Related]
17. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Fukushima T; Sawaki T; Shimoyama K; Karasawa H; Masaki Y; Kawabata H; Ogawa N; Wano Y; Hirose Y; Sugai S; Sutoh H; Itoh H; Kojima Y
Gan To Kagaku Ryoho; 2005 Feb; 32(2):251-3. PubMed ID: 15751644
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
